MELISSA JOHNSON: Open Payments
NPI 1255896338 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,096 in 131 payments from 13 companies in 2025. Trend: 2023 $1,105 · 2024 $2,210 · 2025 $2,096
Food & beverage: $2,096
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 66 | $1,001 |
| Biogen, Inc. | 22 | $416 |
| PFIZER INC. | 19 | $180 |
| Novartis Pharmaceuticals Corporation | 4 | $76 |
| ARGENX US, INC. | 3 | $72 |
| Eisai Inc. | 3 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| Neurocrine BioSciences, Inc. | 3 | $54 |
| Lundbeck LLC | 2 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
Products named: QULIPTA, UBRELVY, TYSABRI, LEQEMBI, NURTEC ODT, KESIMPTA, BOTOX, HYQVIA.
Industry payments across KY — which companies pay providers there.
